483
Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.FDA 483 - Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd, a pharmaceutical manufacturer, was inspected by the FDA from June 10-14, 2019. The inspection revealed significant deficiencies in maintaining written records for evaluating drug product quality standards and incomplete batch production and control records, indicating a lack of adequate process control and documentation. These issues suggest potential risks to drug product quality and consistency.
- Product Type
- Drugs
Open in Dashboard
ID · 7abf56ab-62b7-4f30-9caf-408534202ff9